HILS Hillstream BioPharma Inc.

Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers.

$3.74
As of 01/24/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  01/12/2022
Outstanding shares:  10,295,324
Average volume:  1,945,594
Market cap:   $32,224,364
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -4.84
PS ratio:   0.00
Return on equity:   30.08%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy